Table 3: Overall and individual study incidence of specific types of cancer.

Type of malignancy,  
(%)
Prasad  
et al. [16]
Koh  
et al. [17]
Maoz  
et al. [18]
Louthrenoo  
et al. [19]
Porkodi  
et al. [20]
Wakata  
et al. [21]
Kang  
et al.
[22]
Lee  
et al. [23]
Tani  
et al. [24]
Chen  
et al. [25]
Mustafa and Dahbour  
[26]
Azuma  
et al. [27]
So  
et al. [28]
Teh  
et al. [29]
Total  
(incidence, %)

CountryIndiaSingaporeIsraelThailandIndiaJapanKoreaKoreaJapanTaiwanJordanJapanKoreaMalaysia
NasopharynxNA3 (4.0)0 (0)NANA1 (1.1)NA1 (2.4)1 (4.3)32 (1.9)0 (0)0 (0)2 (1.3)3 (25)43 (1.88)
LungNA4 (5.3)1 (2.8)NANA2 (2.2)NA 1 (2.4)0 (0)27 (1.6)0 (0)0 (0)8 (5.2)0 (0)43 (1.88)
BreastNA1 (1.3)2 (5.7)NANA0 (0)NA3 (7.2)1 (4.3)13 (0.7)0 (0)1 (0.8)4 (2.6)1 (8)26 (1.14)
ColonNA3 (4.0)0 (0)NANA0 (0)NA0 (0)0 (0)10 (0.6)0 (0)3 (2.5)1 (0.7)1 (8)18 (0.79)
GastricNA0 (0)0 (0)NANA2 (2.2)NA1 (2.4)1 (4.3)1 (0.1)0 (0)8 (6.6)5 (3.3)0 (0)18 (0.79)
HepatobiliaryNA2 (2.6)0 (0)NANA4 (4.4)NA1 (2.4)0 (0)9 (0.5)0 (0)0 (0)2 (1.3)0 (0)18 (0.79)
Lymphoma/leukemiaNA0 (0)4 (11.4)NANA0 (0)NA0 (0)0 (0)5 (0.3)0 (0)1 (0.8)1 (0.7)0 (0)11 (0.48)
OvaryNA2 (2.6)1 (2.8)NANA1 (1.1)NA0 (0)0 (0)2 (0.1)0 (0)3 (2.5)1 (0.7)0 (0)10 (0.43)
BladderNA0 (0)1 (2.8)NANA1 (1.1)NA1 (2.4)0 (0)4 (0.2)0 (0)0 (0)0 (0)0 (0)7 (0.31)
ThyroidNA0 (0)0 (0)NANA0 (0)NA1 (2.4)0 (0)3 (0.2)0 (0)0 (0)2 (1.3)0 (0)6 (0.26)
PancreasNA0 (0)0 (0)NANA1 (1.1)NA0 (0)0 (0)2 (0.1)0 (0)2 (1.7)1 (0.7)0 (0)6 (0.26)
EsophagusNA1 (1.3)1 (2.8)NANA0 (0)NA0 (0)0 (0)1 (0.1)0 (0)0 (0)0 (0)0 (0)3 (0.13)
OtherNA1 (1.3)3 (8.5)NANA4 (4.5)NA2 (4.8)0 (0)19 (1.1)0 (0)2 (1.7)0 (0)0 (0)31 (1.36)